Having witnessed time and time again how a smaller sized bio can get pushed around, i dont think it would be such a bad idea. After all, a big pharma could fail clinical trials and you wouldnt even notice it in share price. Small bio achieves fda approval and down she goes?!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.